Clinical Trials

3 results for Prostate Cancer


An Open-label, Single Arm, Roll-over Study to Provide Continued Treatment With Darolutamide in Participants Who Were Enrolled in Previous Bayer Sponsored Studies

  • Condition: Cancer
  • Study ID: NCT04464226
View Trial

A Single-arm, Open-label Phase 4 Study of Darolutamide in Addition to Standard Androgen Deprivation Therapy for Participants in India With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)

  • Condition: Non-metastatic Castration-resistant Prostate Cancer
  • Study ID: NCT05348876
View Trial

A Randomized, Double-blind, Placebo-controlled Phase 2 Study of Darolutamide Versus Placebo in Addition to Standard Androgen Deprivation Therapy for Participants With High-risk Non-metastatic Castration Resistant Prostate Cancer (nmCRPC)

  • Condition: Prostate Cancer
  • Study ID: NCT05171387
View Trial